Innovations in Tumor Profiling: From CGP to Joint Exome and Transcriptome Analysis

Augusta University will share real-world experience with the SureSelect Cancer CGP Assay and the Magnis NGS Prep System, highlighting its automated, high-throughput workflow, robust sensitivity at low input, and support for DNA/RNA targets across solid tumors. Dartmouth will present a scalable joint exome and transcriptome solution developed with Agilent, featuring a unique design strategy, automated workflow, and academic access program. Together, these talks showcase innovative, clinically relevant approaches to comprehensive genomic profiling, including detection of fusions, rare variants, and key biomarkers like TMB, MSI, and HRD.

Note: Products mentioned are for Research Use Only. Not for use in diagnostic procedures.